Biased mutational pattern and quasispecies hypothesis in H5N1 virus

Infection, Genetics and Evolution

Volumn 15, Issue , 2013, Pages 69-76

  Gutiérrez, Ramona Alikiiteaga ^a   Viari, Alain ^b   Godelle, Bernard ^c   Frutos, Roger ^d   Buchy, Philippe ^a  

^a INSTITUT PASTEUR DU CAMBODGE   (Cambodia)

^b INRIA RHÔNE ALPES   (France)

^c INSTITUT DES SCIENCES DE L EVOLUTION   (France)

^d INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

Author keywords

Biased mutational pattern; H5N1; Influenza virus; Polymorphism; Quasispecies

Indexed keywords

ADENOSINE DEAMINASE; PROTEIN ADAR1; RNA DIRECTED RNA POLYMERASE; UNCLASSIFIED DRUG; VIRUS HEMAGGLUTININ; VIRUS PROTEIN; VIRUS RNA; VIRUS SIALIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHICKEN; CONTROLLED STUDY; DEAMINATION; INFLUENZA A (H5N1); INFLUENZA VIRUS A H5N1; MOLECULAR CLONING; MOLECULAR PHYLOGENY; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RNA SEQUENCE; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; VIRUS CELL INTERACTION; VIRUS IDENTIFICATION; VIRUS ISOLATION; VIRUS MORPHOLOGY; VIRUS MUTATION; VIRUS REPLICATION; VIRUS SURVIVAL;

AVES; GALLUS GALLUS; ORTHOMYXOVIRIDAE; RNA VIRUSES;

EID: 84878117215     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2011.10.019     Document Type: Article

References (78)

1. Baccam P., Beauchemin C., Macken C.A., Hayden F.G., Perelson A.S. Kinetics of influenzaA virus infection in humans. J. Virol. 2006, 80:7590-7599.
2. Bass B.L. RNA editing by adenosine deaminases that act on RNA. Annu. Rev. Biochem. 2002, 71:817-846.
3. Biebricher C.K., Eigen M. What is a quasispecies?. Curr. Top. Microbiol. Immunol. 2006, 299:1-31.
4. Bordería A.V., Lorenzo-Redondo R., Pernas M., Casado C., Alvaro T., Domingo E., Lopez-Galindez C. Initial fitness recovery of HIV-1 is associated with quasispecies heterogeneity and can occur without modifications in the consensus sequence. PLoS One 2010, 5:e10319.
5. Bornberg-Bauer E., Chan H.S. Modeling evolutionary landscapes: mutational stability, topology and superfunnels in sequence space. Proc. Natl. Acad. Sci. USA 1999, 96:10689-10694.
6. Bosch F.X., Garten W., Klenk H.-D., Rott R. Proteolytic cleavage of influenza virus hemagglutinins: primary structure of the connecting peptide between HA1 and HA2 determines proteolytic cleavability and pathogenicity of avian influenza viruses. Virology 1981, 113:725-735.
7. Brackney D.E., Brown I.K., Nofchissey R.A., Fitzpatrick K.A., Ebel G.D. Homogeneity of Powassan virus populations in naturally infected Ixodes scapularis. Virology 2010, 402:366-371.
8. Briones C., de Vicente A., Molina-París C., Domingo E. Minority memory genomes can influence the evolution of HIV-1 quasispecies in vivo. Gene 2006, 384:129-138.
9. Briones C., Domingo E., Molina-París C. Memory in retroviral quasispecies: experimental evidence and theoretical model for human immunodeficiency virus. J. Mol. Biol. 2003, 331:213-229.
10. Chen J., Skehel J.J., Wiley D.C. N- and C-terminal residues combine in the fusion-pH influenza hemagglutinin HA2 subunit to form an N cap that terminates the triple-stranded coiled coil. Proc. Natl. Acad. Sci. USA 1999, 96:8967-8972.
11. Chen H., Wen X., To K.K., Wang P., Tse H., Chan J.F., Tsoi H.W., Fung K.S., Tse C.W., Lee R.A., Chan K.H., Yuen K.Y. Quasispecies of the D225G substitution in the hemagglutinin of pandemic influenzaA(H1N1) 2009 virus from patients with severe disease in Hong Kong, China. J. Infect. Dis. 2010, 201:1517-1721.
12. Collins P.J., Haire L.F., Lin Y.P., Liu J., Russell R.J., Walker P.A., Skehel J.J., Martin S.R., Hay A.J., Gamblin S.J. Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants. Nature 2008, 453:1258-1262.
13. Crotty S., Cameron C.E., Andino R. RNA virus error catastrophe: direct molecular test by using ribavirin. Proc. Natl. Acad. Sci. USA 2001, 98:6895-6900.
14. Domingo E., Gomez J. Quasispecies and its impact on viral hepatitis. Virus Res. 2007, 127:131-150.
15. Domingo E., Ruiz-Jarabo C.M., Sierra S., Arias A., Pariente N., Baranowski E., Escarmís C. Emergence and selection of RNA virus variants: memory and extinction. Virus Res. 2002, 82:39-44.
16. Drake J.W., Holland J.J. Mutation rates among RNA viruses. Proc. Natl. Acad. Sci. USA 1999, 96:13910-13913.
17. Duwe S., Schweiger B. A new and rapid genotypic assay for the detection of neuraminidase inhibitor resistant influenzaA viruses of subtype H1N1, H3N2, and H5N1. J. Virol. Methods 2008, 153:134-141.
18. Eckerle L.D., Becker M.M., Halpin R.A., Li K., Venter E., Lu X., Scherbakova S., Graham R.L., Baric R.S., Stockwell T.B., Spiro D.J., Denison M.R. Infidelity of SARS-CoV Nsp14-exonuclease mutant virus replication is revealed by complete genome sequencing. PLoS Pathog. 2010, 6:e1000896.
19. Eigen M. Viral quasispecies. Sci. Am. 1993, 269:42-49.
20. Eigen M., McCaskill J. Molecular quasispecies. J. Phys. Chem. 1988, 92:6881-6891.
21. Emmott E., Wise H., Loucaides E.M., Matthews D.A., Digard P., Hiscox J.A. Quantitative proteomics using SILAC coupled to LC-MS/MS reveals changes in the nucleolar proteome in influenzaA virus-infected cells. J. Proteome Res. 2010, 9:5335-5345.
22. Figlerowicz M., Jackowiak P., Formanowicz P., Kedziora P., Alejska M., Malinowska N., Blazewicz J., Figlerowicz M. Hepatitis C virus quasispecies in chronically infected children subjected to interferon-ribavirin therapy. Arch. Virol. 2010, 155:1977-1987.
23. Fishman S.L., Branch A.D. The quasispecies nature and biological implications of the hepatitis C virus. Infect. Genet. Evol. 2009, 9:1158-1167.
24. Gambaryan A., Tuzikov A., Pazynina G., Bovin N., Balish A., Klimov A. Evolution of the receptor binding phenotype of influenza A (H5) viruses. Virology 2006, 344:432-438.
25. Gao Y., Zhang Y., Shinya K., Deng G., Jiang Y., Li Z., Guan Y., Tian G., Li Y., Shi J., Liu L., Zeng X., Bu Z., Xia X., Kawaoka Y., Chen H. Identification of amino acids in HA and PB2 critical for the transmission of H5N1 avian influenza viruses in a mammalian host. PLoS Pathog. 2009, 5:e1000709.
26. Hasiów-Jaroszewska B., Jackowiak P., Borodynko N., Figlerowicz M., Pospieszny H. Quasispecies nature of Pepino mosaic virus and its evolutionary dynamics. Virus Genes 2010, 41:260-267.
27. Hoffmann E., Lipatov A.S., Webby R.J., Govorkova E.A., Webster R.G. Role of specific hemagglutinin amino acids in the immunogenicity and protection of H5N1 influenza virus vaccines. Proc. Natl. Acad. Sci. USA 2005, 102:12915-12920.
28. Höper D., Hoffmann B., Beer M. Simple, sensitive, and swift sequencing of complete H5N1 avian influenza virus genomes. J. Clin. Microbiol. 2009, 47:674-679.
29. Höper D., Hoffmann B., Beer M. A comprehensive deep sequencing strategy for full-length genomes of influenzaA. PLoS One 2011, 6(4):e19075.
30. Iqbal M., Xiao H., Baillie G., Warry A., Essen S., Londt B., Brookes S.M., Brown I.H., McCauley J.V.V. Within-host variation of avian influenza viruses. Philos. Trans. R. Soc. Lond. B 2009, 364:2739-2747.
31. Jerzak G., Bernard K.A., Kramer L.D., Ebel G.D. Genetic variation in West Nile virus from naturally infected mosquitoes and birds suggests quasispecies structure and strong purifying selection. J. Gen. Virol. 2005, 86:2175-2183.
32. Kaverin N.V., Rudneva I.A., Govorkova E.A., Timofeeva T.A., Shilov A.A., Kochergin-Nikitsky K.S., Krylov P.S., Webster R.G. Epitope mapping of the hemagglutinin molecule of a highly pathogenic H5N1 influenza virus by using monoclonal antibodies. J. Virol. 2007, 81:12911-12917.
33. Kaverin N.V., Rudneva I.A., Ilyushina N.A., Varich N.L., Lipatov A.S., Smirnov Y.A., Govorkova E.A., Gitelman A.K., Lvov D.K., Webster R.G. Structure of antigenic sites on the haemagglutinin molecule of H5 avian influenza virus and phenotypic variation of escape mutants. J. Gen. Virol. 2002, 83:2497-2505.
34. Kongchanagul A., Suptawiwat O., Kanrai P., Uiprasertkul M., Puthavathana P., Auewarakul P. Positive selection at the receptor-binding site of haemagglutinin H5 in viral sequences derived from human tissues. J. Gen. Virol. 2008, 89:1805-1810.
35. Kuroda M., Katano H., Nakajima N., Tobiume M., Ainai A., Sekizuka T., Hasegawa H., Tashiro M., Sasaki Y., Arakawa Y., Hata S., Watanabe M., Sata T. Characterization of quasispecies of pandemic 2009 influenzaA virus (A/H1N1/2009) by de novo sequencing using a next-generation DNA sequencer. PLoS One 2010, 5(4):e10256.
36. Lackenby A., Democratis J., Siqueira M.M., Zambon M.C. Rapid quantitation of neuraminidase inhibitor drug resistance in influenza virus quasispecies. Antivir. Ther. 2008, 13:809-820.
37. Langley W.A., Thoennes S., Bradley K.C., Galloway S.E., Talekar G.R., Cummings S.F., Vareckova E., Russell R.J., Steinhauer D.A. Single residue deletions along the length of the influenza HA fusion peptide lead to inhibition of membrane fusion function. Virology 2009, 394:321-330.
38. Lauring A.S., Andino R. Quasispecies theory and the behavior of RNA viruses. PLoS Pathog. 2010, 6:e1001005.
39. Más A., López-Galíndez C., Cacho I., Gómez J., Martínez M.A. Unfinished stories on viral quasispecies and Darwinian views of evolution. J. Mol. Biol. 2010, 397:865-877.
40. Matrosovich M., Zhou N., Kawaoka Y., Webster R. The surface glycoproteins of H5 influenza viruses isolated from humans, chickens, and wild aquatic birds have distinguishable properties. J. Virol. 1999, 73:1146-1155.
41. Matrosovich M.N., Gambaryan A.S., Teneberg S., Piskarev V.E., Yamnikova S.S., Lvov D.K., Robertson J.S., Karlsson K.-A. Avian influenzaA viruses differ from human viruses by recognition of sialyloligosaccharides and gangliosides and by a higher conservation of the HA receptor-binding site. Virology 1997, 233:224-234.
42. Miotto O., Heiny A.T., Albrecht R., Garcia-Sastre A., Tan T.W., August J.T., Brusic V. Complete-proteome mapping of human influenzaA adaptive mutations: implications for human transmissibility of zoonotic strains. PLoS One 2010, 5:e9025.
43. Ngamurulert S., Limjindaporn T., Auewaraku P. Identification of cellular partners of InfluenzaA virus (H5N1) non-structural protein NS1 by yeast two-hybrid system. Acta Virol. 2009, 53:153-159.
44. OIE World Organisation for Animal Health, 2009. Manual of Diagnostic Tests and Vaccines for Terrestrial Animals 2010, Chapter 2.3.4: Avian Influenza. See: Accessed on 18 July 2011. http://www.oie.int/fileadmin/Home/eng/Health_standards/tahm/2.03.04_AI.pdf.
45. Ojosnegros S., Beerenwinkel N., Antal T., Nowak M.A., Escarmís C., Domingo E. Competition-colonization dynamics in an RNA virus. Proc. Natl. Acad. Sci. USA 2010, 107:2108-2112.
46. Operario D.J., Reynolds H.M., Kim B. Comparison of DNA polymerase activities between recombinant feline immunodeficiency and leukemia virus reverse transcriptases. Virology 2005, 335:106-121.
47. Perdue M.L., García M., Senne D., Fraire M. Virulence-associated sequence duplication at the hemagglutinin cleavage site of avian influenza viruses. Virus Res. 1997, 49:173-186.
48. Philpott M., Hioe C., Sheerar M., Hinshaw V.S. Hemagglutinin mutations related to attenuation and altered cell tropism of a virulent avian influenzaA virus. J. Virol. 1990, 64:2941-2947.
49. Ramakrishnan M.A., Tu Z.J., Singh S., Chockalingam A.K., Gramer M.R., Wang P., Goyal S.M., Yang M., Halvorson D.A., Sreevatsan S. The feasibility of using high resolution genome sequencing of influenzaA viruses to detect mixed infections and quasispecies. PLoS One 2009, 4(9):e7105.
50. Randall R.E., Goodbourn S. Interferons and viruses: an interplay between induction, signalling, antiviral responses and viral countermeasures. J. Gen. Virol. 2008, 89:1-47.
51. Reed L.J., Muench H. A simple method for estimating fifty percent endpoints. Am. J. Hyg. 1938, 27:493-497.
52. Russell R.J., Haire L.F., Stevens D.J., Collins P.J., Lin Y.P., Blackburn G.M., Hay A.J., Gamblin S.J., Skehel J.J. The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design. Nature 2006, 443:45-49.
53. Samuel C.E. Adenosine deaminases acting on RNA (ADARs) are both antiviral and proviral. Virology 2011, 411:180-193.
54. Seligman S.J. Evidence for quasi species in severe acute respiratory syndrome-associated coronavirus deletion mutants. J. Infect. Dis. 2007, 195:609.
55. Seo S.H., Hoffmann E., Webster R.G. Lethal H5N1 influenza viruses escape host anti-viral cytokine responses. Nat. Med. 2002, 8:950-954.
56. Shinya K., Hatta M., Yamada S., Takada A., Watanabe S., Halfmann P., Horimoto T., Neumann G., Kim J.H., Lim W., Guan Y., Peiris M., Kiso M., Suzuki T., Sukuki Y., Kawaoka Y. Characterization of a human H5N1 influenzaA virus isolated in 2003. J. Virol. 2005, 79:9926-9932.
57. Skehel J.J., Wiley D.C. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu. Rev. Biochem. 2000, 69:531-569.
58. Skinner J.A., Eperon I.C. Misincorporation by AMV reverse transcriptase shows strong dependence on the combination of template and substrate nucleotides. Nucleic Acids Res. 1986, 14:6945-6964.
59. Steinhauer D.A. Role of hemagglutinin cleavage for the pathogenicity of influenza virus. Virology 1999, 258:1-20.
60. Stevens J., Blixt O., Tumpey T.M., Taubenberger J.K., Paulson J.C., Wilson I.A. Structure and receptor specificity of the hemagglutinin from an H5N1 Influenza virus. Science 2006, 312:404-410.
61. Sulbaran Y., Gutierrez C.R., Marquez B., Rojas D., Sanchez D., Navas J., Rovallo E., Pujol F.H. HepatitisA virus genetic diversity in Venezuela: exclusive circulation of subgenotype IA and evidence of quasispecies distribution in the isolates. J. Med. Virol. 2010, 82:1829-1834.
62. Suspène R., Petit V., Puyraimond-Zemmour D., Aynaud M.M., Henry M., Guétard D., Rusniok C., Wain-Hobson S., Vartanian J.P. Double-stranded RNA adenosine deaminase ADAR-1-induced hypermutated genomes among inactivated seasonal influenza and live attenuated measles virus vaccines. J. Virol. 2011, 85:2458-2462.
63. Tamura K., Peterson D., Peterson N., Stecher G., Nei M., Kumar S. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol. Biol. Evol. 2011, 28:2731-2739.
64. Taube R., Avidan O., Bakhanshvili M., Hizi A. DNA synthesis exhibited by the reverse transcriptase of mouse mammary tumor virus: processivity and fidelity of misinsertion and mispair extension. Eur. J. Biochem. 1998, 258:1032-1039.
65. Thompson J., Higgins D., Gibson T. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 1994, 22:4673-4680.
66. Van Borm S., Ferreira H.L., van den Berg T. Fine quantification of avian influenza H5N1 escape mutant quasispecies populations using mutation-specific real-time PCR. Avian Dis. 2010, 54:558-564.
67. Van Nimwegen E., Crutchfield J.P., Huynen M. Neutral evolution of mutational robustness. Proc. Natl. Acad. Sci. USA 1999, 96:9716-9720.
68. Walker J.A., Kawaoka Y. Importance of conserved amino acids at the cleavage site of the haemagglutinin of a virulent avian influenzaA virus. J. Gen. Virol. 1993, 74:311-314.
69. Ward S.V., George C.X., Welch M.J., Liou L.Y., Hahm B., Lewicki H., de la Torre J.C., Samuel C.E., Oldstone M.B. RNA editing enzyme adenosine deaminase is a restriction factor for controlling measles virus replication that also is required for embryogenesis. Proc. Natl. Acad. Sci. USA 2011, 108:331-336.
70. Watanabe, Y., Ibrahim, M.S., Ellakany, H., Abd El-Hamid, H.S., Ikuta, K., 2011. Genetic diversification of H5N1 Highly Pathogenic Avian InfluenzaA virus during replication in wild ducks. J. Gen. Virol. [Epub ahead of print].
71. Wilke C.O. Adaptive evolution on neutral networks. Bull. Math. Biol. 2001, 63:715-730.
72. Wilke C.O. Quasispecies theory in the context of population genetics. BMC Evol. Biol. 2005, 5:44.
73. Wilke C.O., Adami C. Evolution of mutational robustness. Mut. Res. 2003, 522:3-11.
74. Yamada S., Suzuki Y., Suzuki T., Le M.Q., Nidom C.A., Sakai-Tagawa Y., Muramoto Y., Ito M., Kiso M., Horimoto T., Shinya K., Sawada T., Kiso M., Usui T., Murata T., Lin Y., Hay A., Haire L.F., Stevens D.J., Russell R.J., Gamblin S.J., Skehel J.J., Kawaoka Y. Haemagglutinin mutations responsible for the binding of H5N1 influenzaA viruses to human-type receptors. Nature 2006, 444:378-382.
75. Yen H.-L., Herlocher L.M., Hoffmann E., Matrosovich M.N., Monto A.S., Webster R.G., Govorkova E.A. Neuraminidase inhibitor-resistant influenza viruses may differ substantially in fitness and transmissibility. Antimicrob. Agents Chemother. 2005, 49:4075-4084.
76. Yen H.-L., Ilyushina N.A., Salomon R., Hoffmann E., Webster R.G., Govorkova E.A. Neuraminidase inhibitor-resistant recombinant A/Vietnam/1203/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo. J. Virol. 2007, 81:12418-12426.
77. Zambon M., Potter C.W. Influenza. Principles and practice of clinical virology 2009, John Wiley & Sons, Chichester. sixth edition. A.J. Zuckerman, J.E. Banatvala, B.D. Schoub, P.D. Griffiths, P. Mortimer (Eds.).
78. Zhou H., Zhu J., Tu J., Zou W., Hu Y., Yu Z., Yin W., Li Y., Zhang A., Wu Y., Yu Z., Chen H., Jin M. Effect on virulence and pathogenicity of H5N1 influenza A virus through truncations of NS1 eIF4GI binding domain. J. Infect. Dis. 2010, 202:1338-1346.